Patients with systemic lupus erythematosus with a history of cutaneous lupus erythematosus are more likely to have high ...

The FDA has lifted one of the two clinical holds placed on Kezar Life Sciences’ zetomipzomib, leading the biotech to speculate on whether to reignite another program for the same drug that remains ...

Earlier use of combination therapies is purported to improve outcomes in many disease states, including lupus nephritis.

Viewing lupus decision aids without interruption leads to better patient-reported outcomes, regardless of whether they are ...

Find out more about lupus: the symptoms, types, causes, and who is at risk for developing this chronic autoimmune disease.

The FDA has approved Benlysta for SC administration using an autoinjector in patients 5 years of age and older with active LN.

Oral cancer is a growing public health concern, particularly in South Asia, where it affects tens of thousands each year. In ...

Aurinia Pharma and partner Otsuka have secured approval in the EU for Lupkynis, billed as the first oral treatment for active nephritis in patients with the autoimmune disease systemic lupus ...

Novartis' soon-to-be-divested Sandoz unit has positive clinical trial data in hand for a biosimilar of Amgen's blockbuster osteoporosis therapy Prolia (denosumab), clearing the way for regulatory ...

Ivermectin, which is used to treat certain parasitic infections, can cause side effects. Learn about its mild and serious side effects and how to manage them.

Ulcerative colitis can affect more than just your gastrointestinal tract — it can affect your skin, too. Learn about symptoms and treatments for better skin health.